← ANALYST RATINGS · TIPRANKS

Afya (AFYA): analyst forecast and price target

$14.53 +0.07% close 16.10.26 · market cap $1.2B · Consumerdefensive · Education & Training Services
Price targets and ratings of

Analyst consensus

Moderate Buy

2 Buy0 Hold0 Sell

Ratings of 2 analysts in the last 3 months

12-month forecast

$18.00+23.9% upside

Based on 2 price targets given in the last 3 months, the average target is $18.00, the highest $19.00, the lowest $17.00. The average is +23.9% from the last price of $14.53.

$12.50$15.00$17.50Jan 26AprJulOctJan 27AprJulOctHigh$19.00Average$18.00Low$17.00
Highest target $19.00 Average target $18.00 Lowest target $17.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Marcelo Santos★★★★★★★★★★#1771 · hits 58% · avg +15.9% J.P. Morgan $21.00 → $19.00−9.5% Buy +30.8% Assigned 07.10.26on TipRanks 05:20 +0.1%next day +2.2% · 5 days +4.5%
Marcio Osako★★★★★★★★★★#10115 · hits 33% · avg −15.1% Bradesco $17.00 Buy +17.0% Upgrade 24.09.26on TipRanks 08:15 +1.2%next day −5.9% · 5 days −11.6%
Flavio Yoshida★★★★★★★★★★#9482 · hits 0% · avg −5.3% Bank of America Securities $17.00 Hold +17.0% Reiterated 22.04.26on TipRanks 07:50 −2.3%next day −7.9% · 5 days −10.1%
Mauricio Cepeda★★★★★★★★★★#10089 · hits 47% · avg −4.3% Morgan Stanley $17.50 → $16.00−8.6% Sell +10.1% Downgrade 13.02.26on TipRanks 05:25 −3.0%next day −1.2% · 5 days −1.1%
Samuel Alves BTG Pactual $17.00 Hold +17.0% Downgrade 21.01.26on TipRanks 23:05 +2.0%next day +2.3% · 5 days +3.7%
Andre Salles★★★★★★★★★★#5796 · hits 71% · avg +12.6% UBS $18.00 → $16.00−11.1% Hold +10.1% Downgrade 16.01.26on TipRanks 05:10 −3.1%next day +0.1% · 5 days +5.9%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Afya

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Marcelo Santos★★★★★★★★★★J.P. Morgan · #1771
Hits 58%42 of 73 Average return +15.9%
1 year Mauricio Cepeda★★★★★★★★★★Morgan Stanley · #10089
Hits 47%7 of 15 Average return −4.3%
2 years Mauricio Cepeda★★★★★★★★★★Morgan Stanley · #10089
Hits 47%7 of 15 Average return −4.3%

Most profitable

3 months Marcelo Santos★★★★★★★★★★J.P. Morgan · #1771
Hits 58%42 of 73 Average return +15.9%
1 year Mauricio Cepeda★★★★★★★★★★Morgan Stanley · #10089
Hits 47%7 of 15 Average return −4.3%
2 years Mauricio Cepeda★★★★★★★★★★Morgan Stanley · #10089
Hits 47%7 of 15 Average return −4.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 07.10.26: target $18.00 at a price of $13.91 (+29.4%); now: $18.00 at $14.53 (+23.9%).

$12.50$15.00$17.50Sep 15Oct 1Oct 15Top analysts$19.00Average target$18.00Price$14.53

PriceAverage targetTop analysts’ target

Recommendation trend

0246321Oct 25221Nov211Dec124Jan 261141Feb141Mar31Apr2May3Jun1Jul1Aug1Sep2Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy000012
Hold231100
Sell000000

Earnings and sales forecast

Next report: 12.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.39 (from $0.35 to $0.46). Last quarter: $0.44.

Sales

Next quarter’s sales estimate — $199M (from $196M to $202M). Last quarter: $192M.

Best top-analyst consensus in the sector · Consumerdefensive

JBSJBS
MAMAMama's Creations
WMTWalmart
BGBunge Global
TPBTurning Point Brands
About Afya
  • CEO: Virgilio Deloy Capobianco Gibbon
  • Employees: 9,395
  • Rua Paraíba, No. 330, Belo Horizonte, MG, 30130-917, BR
  • institucional.afya.com.br

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school sea

Data from the stock’s TipRanks forecast page, read 36 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗